You just read:

BOTOX® (Allergan's botulinum toxin type A) Given Final Guidance from the National Institute for Health and Clinical Excellence (NICE) for the Prevention of Chronic Migraine in Patients Who Have Failed Previous Treatments

News provided by

Allergan

27 Jun, 2012, 07:00 BST